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AbstrAct
Introduction Pregnancy is associated with several 
hormonal changes which influence the developing 
fetus. Variations in maternal endogenous hormones and 
prepregnancy use of hormonal preparations have been 
linked to asthma and allergy in the offspring, but findings 
are inconsistent. We plan to undertake a systematic review 
to synthesise the evidence on the association between 
endogenous and exogenous maternal sex hormones and 
the risk of asthma and allergy in the offspring.
Methods and analysis We will search Medline, Embase, 
Cochrane Library, Institute of Scientific Information Web 
of Science, Cumulative Index of Nursing and Allied Health, 
Scopus, Google Scholar, Allied and Complementary 
Medicine Database, Global Health, Psychological 
Information (PsycINFO), Centre for Agriculture and 
Bioscience (CAB) International and WHO Global Health 
Library from inception until 2016 to identify relevant 
studies on the topic. Additional studies will be identified 
by searching databases of proceedings of international 
conferences, contacting international experts in the field 
and searching the references cited in identified studies. 
We will include analytical epidemiological studies. Two 
researchers will independently screen identified studies, 
undertake data extraction and assess risk of bias in 
eligible studies, while a third reviewer will arbitrate any 
disagreement. We will use the Effective Public Health 
Practice Project tool to assess the risk of bias in the 
studies. We will perform a random-effects meta-analysis 
to synthesise the evidence. We will use the Grading 
of Recommendations Assessment, Development and 
Evaluation approach to rate the strength and quality of the 
overall evidence with respect to each outcome.
Ethics and dissemination Ethical approval is not 
required since the study is a systematic review of 
published literature. Our findings will be reported in a 
peer-reviewed scientific journal.
PROSPERO registration number CRD42016048324
IntroductIon
Pregnancy is associated with numerous adjust-
ments that occur in the endocrine system, 
which are normal and necessary adaptations 
that adequately accommodate the fetus.1–5 
These adjustments include oestrogen and 
progesterone hormonal changes, which see 
steady levels of increase and are essential in 
suppressing the hypothalamic axis and the 
menstrual cycle.1–5 Human chorionic gonad-
otropin also increases and helps to sustain 
the production of progesterone by the corpus 
luteum.4 5 Prolactin levels increase as a result 
of the maternal pituitary gland. Adrenal 
hormones such as cortisol and aldosterone 
increase, as do parathyroid hormones, which 
lead to greater uptake of calcium in the gut 
and reabsorption in the kidney.1–5
Oestrogen plays a key role in the well-being 
and development of the fetus.4 5 Increases in 
the levels of progesterone production help 
to relax bronchiolar smooth muscle and are 
associated with an increase in minute ventila-
tion, which can rise to up to 50% greater than 
prepregnancy levels.4 5 Both oestrogen and 
progesterone are thought to act as immuno-
steroids, although the effect on the direction 
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Protocol
Strengths and limitations of this study
 ► This is the first systematic review examining the role 
of endogenous and exogenous maternal sex steroid 
hormones and risk of asthma and allergy in the 
offspring and thus will contribute to knowledge on 
the fetal origin of allergy and asthma.
 ► We will identify studies from major healthcare 
databases without using geographical or language 
limitations, as well as including an extensive 
review on all of the current literature, ongoing and 
unpublished studies and will employ replicable 
methods.
 ► Existing studies may be heterogeneous, thus making 
it difficult to derive pooled estimates from included 
studies.
group.bmj.com on July 20, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Talovic M, et al. BMJ Open 2017;7:e014637. doi:10.1136/bmjopen-2016-014637
Open Access 
of shift in the T cells is not entirely clear.4 5 However, it 
has been suggested that the observed changes in levels 
of maternal endogenous sex steroid hormones, including 
oestrogen, progesterone and testosterone, during preg-
nancy may influence subsequent risk of asthma and 
allergy in the offspring.6–9
Prepregnancy use of oral contraceptive pills, including 
combined pills and progestin-only pills, has been postu-
lated to modulate the risk of asthma and allergy in the 
offspring through possible disruption of the immunolog-
ical balance.10–16 Wjst and Dold were the first to postulate 
that the use of contraceptive pills before pregnancy may 
influence subsequent risk of asthma and allergy in the 
offspring.10 According to their hypothesis, the effect 
of contraceptive pills may last for several years even 
after discontinuation; however, the dosage, frequency 
and timing of use of oral contraceptive pills which may 
instigate the immune effect that can result in increased 
offspring asthma and allergy risks are unclear.10
Although several studies have now investigated the role 
of both endogenous and exogenous sex steroid hormones 
during pregnancy in the development of asthma and 
allergy in the offspring, findings are inconsistent. To 
clarify the underlying evidence base, we plan to under-
take a systematic review to identify, critically appraise and 
synthesise studies on the role of changes in endogenous 
sex steroid hormones during pregnancy and the role of 
exogenous steroid hormone use before pregnancy in the 
development of asthma and allergy in the offspring.
Methods
This protocol is reported following the recommendations 
of the Preferred Reporting Items for Systematic review 
and Meta-Analysis Protocols (PRISMA-P) checklist.17
eligibility criteria
Types of studies
All analytical observational epidemiological studies: 
cohort studies, case control studies and cross-sectional 
studies on the topic are eligible for inclusion. Animal 
studies, case series, case studies and reviews will be 
excluded.
Participants
We are interested in the role of changes in endogenous 
sex hormones and in the use of exogenous sex hormones 
in the year before pregnancy and during pregnancy. We 
will therefore include women during preconception and 
pregnancy and their offspring of any age.
Years considered
We will include studies published from the inception of 
each database searched until the end of 2016.
Language
We will have no language restrictions and we will 
endeavour to translate literature published in languages 
other than English whenever this is possible.
Information sources
Database searches and other sources to identify studies
To identify relevant studies, we will search Medline, 
Embase, Cochrane Library, Institute of Scientific Informa-
tion (ISI) Web of Science, Cumulative Index of Nursing 
and Allied Health, Scopus, Google Scholar, Allied and 
Complementary Medicine Database, Global Health, 
Psychological Information (PsycINFO), Centre for Agri-
culture and Bioscience (CAB) International and WHO 
Global Health Library. Additional references will be iden-
tified by searching the references cited in eligible studies; 
by searching databases of the proceedings of interna-
tional conferences, such as ISI Conference Proceedings 
Citation Index via Web of Science, Zetoc British Library's 
Electronic Table of Contents (ZETOC) and by contacting 
a panel of international experts and authors who have 
published in the field. We will search trial registries, such 
as Current Controlled Trials (http://www. controlled- 
trials. com),  ClinicalTrials. gov (http://www. clinicaltrials. 
gov), and Australian and New Zealand Clinical Trials 
Registry (http://www. anzctr. org. au) to identify ongoing 
studies.
Search strategy
We have prepared a search strategy using the Ovid inter-
face for Medline (see online supplementary appendix 1) 
to identify and retrieve relevant studies. We will adapt this 
search strategy when searching the other databases.
study records
Data management
We will use Endnote Library for managing the references 
identified from the databases. All records will be exported 
to Endnote Library for onward study screening, de-dupli-
cation and overall management of the retrieved records.
Selection process
Two reviewers (MT and NM) will independently screen 
the titles and/or abstracts and full texts of potentially 
eligible studies. A third reviewer (BN) will arbitrate any 
disagreements.
Data extraction
Two reviewers will independently extract relevant 
study data from eligible studies onto a customised data 
extraction form, while a third reviewer will arbitrate any 
discrepancies. The data extraction form will be piloted 
using a select sample of the eligible studies prior to use in 
extracting data from all studies.
Data items
We will produce descriptive summary tables to summarise 
eligible studies. All relevant study data will be tabulated 
and as a minimum the tables will include the following: 
study author, country of study, year of publication, study 
design, size of study population, source of study popula-
tion, type of exposure studied (endogenous vs exogenous 
sex hormones and the specific types) and method of 
assessment, time before pregnancy and trimester during 
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pregnancy exposure was ascertained, length of follow-up 
(for follow-up studies), confounding factors considered, 
study outcomes and methods of assessment, analysis 
methods and key results. The PRISMA checklist will guide 
the reporting of the systematic review.18
Types of exposures
We will include studies that have investigated the role of 
all relevant endogenous sex steroid hormones (including 
oestrogen, progesterone, testosterone) and exogenous 
sex hormones (including oestrogen only, progesterone 
only and combined oral contraceptives).
Outcomes and prioritisation
Our primary outcomes will include: objectively measured 
or self-reported asthma, atopic dermatitis/eczema, 
allergic rhinitis, anaphylaxis, urticaria, angioedema and 
food allergy. The secondary outcomes will include: atopic 
sensitisation as defined either by skin prick test or raised 
antigen specific IgE; objective and subjective measures of 
disease severity and impact on quality of life, including 
asthma exacerbations, use of asthma medications, hospi-
talisation for asthma, wheeze as defined by self-report 
or objective diagnosis; indicators of airway function 
including (peak expiratory flow, forced expiratory 
volume in 1 s, forced vital capacity, forced expiratory flow 
rate or alternative age appropriate pulmonary function 
tests (oscillometry or exhaled nitric oxide analysis)) and 
measures of patient-reported health-related quality of life 
related to asthma or allergy. We will also assess the impact 
of sex hormones on any allergic or respiratory outcome.
Risk of bias in individual studies
Two reviewers (MT and NM) will independently evaluate 
the risk of bias in eligible studies and consensus will be 
reached through discussion; a third reviewer (BN) will 
arbitrate any discrepancies. We will use the Effective 
Public Health Practice Project tool (EPHPP) (www. ephpp. 
ca) to appraise the risk of bias in studies. The EPHPP tool 
allows for the grading of key components of the studies, 
including: suitability of the study design for the research 
question; risk of selection bias; exposure measurement; 
outcome assessment (giving a higher grade to objectively 
defined outcomes than subjectively defined outcomes) 
and generalisability of findings. From these compo-
nent-specific gradings, we will derive an overall grading 
for each study.
Data synthesis
All analyses will be undertaken separately for studies 
on exogenous hormones and studies on endogenous 
hormones. We will synthesise the data both narratively and 
quantitatively. For quantitative synthesis, we will perform 
random-effects meta-analysis to combine the estimates 
from studies judged to be clinically, methodologically 
and statistically homogeneous. Heterogeneity between 
studies will be quantified using the I2 statistic. For anal-
yses investigating the role of endogenous sex hormones, 
data syntheses will be undertaken by pregnancy trimester. 
Subgroup analyses will be performed according to age 
of offspring at onset/diagnosis of outcomes (where 
possible using the following age groups: <5 years, 5–12 
years, >12 years), sex, parity and for analyses investigating 
the role of exogenous sex hormones, time of exposure 
before pregnancy (eg, 6 months vs 12 months before 
pregnancy). Using the grading derived from the quality 
appraisal of eligible studies, we will perform sensitivity 
analyses to evaluate the robustness of our findings and 
whether they are influenced by the risk of bias in studies. 
The meta-analyses will be performed using the statistical 
package Stata V.14.
Publication bias
We will evaluate the potential for publication bias by using 
funnel plots and Begg and Egger tests.19 20
confidence in the cumulative estimate
We will evaluate and grade the strength and quality of 
the overall evidence emanating from the review using the 
Grading of Recommendations Assessment, Development 
and Evaluation approach.21
We do not envisage making clinical recommendations 
from this largely and exclusively epidemiological evidence 
base. There may be no need to interfere with pregnancy 
hormones in otherwise healthy females. However, if 
prenatal endogenous hormones contribute to the risk of 
allergy and asthma in the offspring, understanding this 
role and the mechanisms through which these hormones 
operate is essential for the field, as this will contribute to 
knowledge of the fetal origin of allergy and asthma. More-
over, since studies have now reported such associations, 
with varying results, a synthesis of the underlying evidence 
is essential in clarifying any putative role of prenatal sex 
hormones in the development of asthma and allergy in 
the offspring.
ethIcs and dIsseMInatIon
We completed the Usher Institute of Population Health 
Sciences and Informatics Level 1 ethics self-assessment 
form, which indicated that no further ethical permission 
was required for this work as the study will only involve 
review of the published literature. Our findings will be 
reported in a peer-reviewed scientific journal.
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